Home Press Releases Digital Therapeutics Market Growth Projected to Reach USD 40 Billion by 2035, at a 16.88% CAGR

Digital Therapeutics Market Growth Projected to Reach USD 40 Billion by 2035, at a 16.88% CAGR

by Newsroom


(EMAILWIRE.COM, June 17, 2025 ) Digital Therapeutics Market Overview

As per MRFR analysis, the Digital Therapeutics Market Size was estimated at 6.16 (USD Billion) in 2023. The Digital Therapeutics Market Industry is expected to grow from 7.2(USD Billion) in 2024 to 40 (USD Billion) by 2035. The Digital Therapeutics Market CAGR (growth rate) is expected to be around 16.88% during the forecast period (2025 – 2035).

Market Dynamics

The digital therapeutics market is rapidly evolving, driven by a surge in chronic disease prevalence, growing healthcare costs, and the global push toward more accessible, tech-enabled healthcare solutions. These software-based therapeutic interventions are gaining traction as they offer evidence-based treatments that can be used independently or alongside traditional medical therapies, especially for conditions like diabetes, obesity, mental health disorders, and cardiovascular diseases.

Sample Copy of the Report: 

https://www.marketresearchfuture.com/sample_request/6492

Clinical Validation and FDA Approvals

One of the most critical trends is the increasing number of FDA-cleared or CE-marked DTx solutions, establishing digital therapeutics as credible, mainstream treatment options. Pear Therapeutics has been a pioneer in this space, with its reSET® and Somryst® therapies approved for substance use disorder and chronic insomnia, respectively. Their regulatory success has opened pathways for other DTx companies to seek similar endorsements.

Focus on Mental and Behavioral Health

With rising rates of anxiety, depression, and burnout, particularly in the wake of the pandemic, mental health has become a dominant therapeutic focus for DTx. Companies like SilverCloud Health, Ginger, Mindstrong Health, and Big Health are leading the way with digital cognitive behavioral therapy (CBT) programs, teletherapy integration, and AI-driven mental health tools.

Chronic Disease Management

Digital therapeutics are proving invaluable in managing chronic illnesses such as diabetes, hypertension, and cardiovascular diseases. Livongo Health, DarioHealth, and WellDoc are at the forefront of this movement, delivering real-time feedback and personalized coaching to help patients manage conditions with better adherence and fewer complications.

Integration with AI and Wearable Devices

AI and machine learning are enabling deeper personalization and predictive insights. Biofourmis, for example, combines AI with wearable biosensors to provide real-time monitoring and intervention for heart failure and other serious conditions. Similarly, Omada Health uses data analytics and behavioral science to improve outcomes in metabolic and musculoskeletal health.

Gamification and Engagement

To boost user engagement and improve therapy adherence, companies like Akili Interactive and Happify Health are incorporating gamification into their platforms. Akili’s EndeavorRx became the first FDA-approved video game-based therapy, targeting pediatric ADHD and showcasing how digital games can offer therapeutic benefits when backed by science.

You Can Purchase Complete Report: 

https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=6492

Top Companies Included in This Report:

Better Therapeutics

Mindstrong Health

Pear Therapeutics

SilverCloud Health

Knowach

Akili Interactive

DarioHealth

Well Doc

Omada Health

Ginger

Livongo Health

Zecotek Photonics

Happify Health

Big Health

Biofourmis

Digital Therapeutics Market Segmentation Insights

Digital Therapeutics Market Application Outlook

Chronic Disease Management

Mental Health Disorders

Preventive Care

General Wellness

Digital Therapeutics Market Delivery Mode Outlook

Software

Device

Platform

Key Regions/Countries Classified as Follows: 

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Read More:

https://www.marketresearchfuture.com/reports/digital-therapeutics-market-6492

Reasons to Purchase This Report:

Regional Insights: Understand regional consumption patterns and factors influencing the market in different areas.

Global Opportunities & Threats: Discover opportunities and challenges faced by global suppliers in the IELTS Training Platform sector.

Growth Potential: Identify the fastest-growing regions and sectors.

Competitive Landscape: Review market rankings, recent product launches, partnerships, expansions, and acquisitions of leading companies.

Company Profiles: Access comprehensive corporate profiles, including company overviews, insights, product benchmarks, and SWOT analyses of key market players.

Market Outlook: Get current and future market outlooks, including recent developments, growth opportunities, drivers, challenges, and regional constraints

FAQ:

What is the scope of this report?

Does this report estimate the current market size?

Does the report provide market size in terms of Value (US$ Mn)?

Which segments are covered in this report?

What are the key factors covered in this report?

Does this report offer customization options?

Other Related Reports from Market Research Future References

Transcatheter Market: https://www.marketresearchfuture.com/reports/transcatheter-market-6218

Surgical Staplers Market: https://www.marketresearchfuture.com/reports/surgical-stapler-market-6382

Hemostats Market: https://www.marketresearchfuture.com/reports/hemostats-market-6413

Blockchain Technology in Healthcare Market: https://www.marketresearchfuture.com/reports/blockchain-technology-healthcare-market-6475

Liquid Handling System Market: https://www.marketresearchfuture.com/reports/liquid-handling-system-market-6588



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC